What is OCSAW's health score?

Oculis Holding AG (OCSAW) has a TradeApes health score of 38 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is OCSAW's estimated fair value?

Based on our 5-year discounted cash flow model, Oculis Holding AG's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is OCSAW undervalued or overvalued?

Our model currently rates OCSAW as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for OCSAW... Refresh in a moment for the full analysis.

Oculis Holding AG (OCSAW)

Healthcare Fair Value High weak

Updated: 2026-04-21

TradeApes Score

reduce

Financial Strength

35 Weak

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

20 Stressed

Risk

65 Healthy

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.